跳至主要内容
临床试验/NCT07685860
NCT07685860招募中不适用

Monoamine Oxidase A PET/CT in Various MAO-A-Related Disease

Tianjin Medical University3 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2026年6月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
3
主要终点
Standardized uptake value (SUV)

研究概览

简要总结

To evaluate the potential usefulness of 18F-AIPF-1026 positron emission tomography/ computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various MAO-A-related disease patients.

详细描述

Subjects with various Tau-related disease patients underwent 18F-AIPF-1026 PET/CT either for an initial assessment or for recurrence detection.

Lesions uptake was quantified by the maximum standard uptake value (SUVmax). The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of 18F-AIPF-1026 PET/CT were calculated.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - (i) adult patients (aged 18 years or order); (ii) patients with suspected or new diagnosed or previously treated depression (supporting evidence may include MRI, CT, tumor markers and pathology report); (iii) patients who had scheduled MAO-A PET/CT scan; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.

排除标准

  • - (i) patients with non-malignant lesions; (ii) patients with pregnancy; (iii) the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.

研究组 & 干预措施

Single Group Assignment

Each subject receive a single intravenous injection of 18F-aipf-1026, and undergo PET/CT or MRI imaging within the specificed time.

干预措施: Diagnostic Test: 18F-AIPFA-1026 (Diagnostic Test)

结局指标

主要结局

Standardized uptake value (SUV)

时间窗: 30 days

Standardized uptake value (SUV) of 18F-AIPF-1026 for each target lesion of subject or suspected primary tumor or/and metastasis.

次要结局

  • Diagnostic efficacy(30 days)

研究者

发起方
Tianjin Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Shaobo Yao, PhD

Prof.

Tianjin Medical University

研究点 (3)

Loading locations...

相似试验